1. Home
  2. ULY vs NBY Comparison

ULY vs NBY Comparison

Compare ULY & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Urgent.ly Inc.

ULY

Urgent.ly Inc.

HOLD

Current Price

$2.29

Market Cap

4.0M

Sector

N/A

ML Signal

HOLD

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$1.18

Market Cap

6.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ULY
NBY
Founded
2013
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
6.3M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
ULY
NBY
Price
$2.29
$1.18
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$11.50
N/A
AVG Volume (30 Days)
41.2K
132.3K
Earning Date
11-12-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.47
Revenue
$127,932,000.00
$10,302,000.00
Revenue This Year
N/A
$23.91
Revenue Next Year
$18.95
$32.05
P/E Ratio
N/A
$47.02
Revenue Growth
N/A
390.34
52 Week Low
$1.74
$0.46
52 Week High
$17.99
$4.44

Technical Indicators

Market Signals
Indicator
ULY
NBY
Relative Strength Index (RSI) 49.99 57.09
Support Level $1.75 $1.00
Resistance Level $1.93 $1.11
Average True Range (ATR) 0.16 0.10
MACD 0.05 0.03
Stochastic Oscillator 52.69 97.26

Price Performance

Historical Comparison
ULY
NBY

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: